切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 55 -56. doi: 10.3877/cma.j.issn.1674-0793.2020.01.016

所属专题: 经典病例 经典病例 文献

病例报告

合并催乳素升高男性乳腺癌一例
刘威1, 陈伟光1, 梁蓉1, 李梅1,()   
  1. 1. 510220 广州市红十字会医院 暨南大学医学院附属广州红十字会医院乳腺科
  • 收稿日期:2019-04-04 出版日期:2020-02-01
  • 通信作者: 李梅
  • 基金资助:
    广州市卫生健康科技项目(20191A011016); 暨南大学附属广州红十字会医院科研项目(2018-08)

Male breast cancer combined with the increasing of prolactin: A case report

Wei Liu1, Weiguang Chen1, Rong Liang1   

  • Received:2019-04-04 Published:2020-02-01
引用本文:

刘威, 陈伟光, 梁蓉, 李梅. 合并催乳素升高男性乳腺癌一例[J]. 中华普通外科学文献(电子版), 2020, 14(01): 55-56.

Wei Liu, Weiguang Chen, Rong Liang. Male breast cancer combined with the increasing of prolactin: A case report[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(01): 55-56.

[1]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2]
Giordano SH. Breast cancer in men[J]. N Engl J Med, 2018, 379 (14): 1385-1386.
[3]
Fabián-Estrada E, Flores-Rangel GA, Mosiñoz-Montes R, et al. Breast cancer in males, case presentation and literature review[J]. Rev Med Inst Mex Seguro Soc, 2018, 56(4): 424-428.
[4]
Silvestri V, Barrowdale D, Mulligan AM, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2[J]. Breast Cancer Res, 2016, 18(1): 15.
[5]
Miao H, Verkooijen HM, Chia KS, et al. Incidence and outcome of male breast cancer: an international population-based study[J]. J Clin Oncol, 2011, 29 (33): 4381-4386.
[6]
Keinan-Boker L, Levine H, Leiba A, et al. Adolescent obesity and adult male breast cancer in a cohort of 1 382 093 men[J]. Int J Cancer, 2018, 142(5): 910-918.
[7]
Sørensen HT, Friis S, Olsen JH, et al. Risk of breast cancer in men with liver cirrhosis[J]. Am J Gastroenterol, 1998, 93(2): 231-233.
[8]
Olsson H, Alm P, Kristoffersson U, et al. Hypophyseal tumor and gynecomastia preceding bilateral breast cancer development in a man[J]. Cancer, 1984, 53(9): 1974-1977.
[9]
Harris JR. Diseases of the breast[M]. U.S.A: LIPPINCOTT WILLIAMS & WILKINS, 2012: 1127-1135.
[10]
Zheng Y, Mo W, Yu Y, et al. Breast carcinoma associated with prolactinoma: A case report[J]. Cancer Biol Ther, 2017, 18(3): 132-136.
[11]
Goffin V. Prolactin receptor targeting in breast and prostate cancers: new insights into an old challenge[J]. Pharmacol Ther, 2017, 179: 111-126.
[12]
Satram-Hoang S, Ziogas A, Anton-Culver H. Risk of second primary cancer in men with breast cancer[J]. Breast Cancer Res, 2007, 9(1): R10.
[13]
Fentiman IS. Surgical options for male breast cancer[J]. Breast Cancer Res Treat, 2018, 172 (3): 539-544.
[14]
焦武,姚峰. 男性乳腺癌的研究进展[J]. 中华实用诊断与治疗杂志, 2018, 32(5): 518-520.
[15]
张铭钊,张建国. 男性乳腺癌的诊断与治疗[J]. 中国现代普通外科进展, 2017, 20(11): 922-924.
[16]
Jordan VC. Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention[J]. Cancer Treat Rev, 1990, 17(1): 15-36.
[17]
陈峰,邱丽贞. 芳香化酶抑制剂在早期男性乳腺癌治疗中的生物学效益及临床意义[J]. 中华医学杂志, 2014, 94(4): 273-275.
No related articles found!
阅读次数
全文


摘要